This cancer subtype is characterized by the absence of molecular targets [1,4,5,9], specifically hormone membrane receptors and Her2neu, which, in contrast to the Luminal A/B and Her2neu subtypes, greatly complicates the selection of appropriate targeted therapy [1,2,3,4,5,6,7,8,9]. The gene discussed is ERBB2; the disease is cancer.